- Home
- MRKR vs AZ Comparison
MRKR vs AZ Comparison
Compare MRKR & AZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRKR
- AZ
- Stock Information
- Founded
- MRKR N/A
- AZ 2018
- Country
- MRKR United States
- AZ Canada
- Employees
- MRKR N/A
- AZ N/A
- Industry
- MRKR Biotechnology: Pharmaceutical Preparations
- AZ Industrial Machinery/Components
- Sector
- MRKR Health Care
- AZ Industrials
- Exchange
- MRKR Nasdaq
- AZ Nasdaq
- Market Cap
- MRKR 35.8M
- AZ 36.4M
- IPO Year
- MRKR N/A
- AZ N/A
- Fundamental
- Price
- MRKR $3.50
- AZ $6.60
- Analyst Decision
- MRKR Strong Buy
- AZ
- Analyst Count
- MRKR 1
- AZ 0
- Target Price
- MRKR $19.00
- AZ N/A
- AVG Volume (30 Days)
- MRKR 34.9K
- AZ 168.0K
- Earning Date
- MRKR 11-22-2024
- AZ 11-13-2024
- Dividend Yield
- MRKR N/A
- AZ N/A
- EPS Growth
- MRKR N/A
- AZ N/A
- EPS
- MRKR N/A
- AZ N/A
- Revenue
- MRKR $3,727,435.00
- AZ $6,628,000.00
- Revenue This Year
- MRKR $35.94
- AZ $30.95
- Revenue Next Year
- MRKR N/A
- AZ $646,436.00
- P/E Ratio
- MRKR N/A
- AZ N/A
- Revenue Growth
- MRKR N/A
- AZ N/A
- 52 Week Low
- MRKR $2.44
- AZ $0.85
- 52 Week High
- MRKR $6.16
- AZ $6.66
- Technical
- Relative Strength Index (RSI)
- MRKR 46.47
- AZ 73.03
- Support Level
- MRKR $3.52
- AZ $4.66
- Resistance Level
- MRKR $3.90
- AZ $5.55
- Average True Range (ATR)
- MRKR 0.40
- AZ 0.57
- MACD
- MRKR -0.08
- AZ 0.04
- Stochastic Oscillator
- MRKR 0.00
- AZ 88.56
About MRKR Marker Therapeutics Inc.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart.
About AZ A2Z Smart Technologies Corp.
A2Z Cust2Mate Solutions Corp is engaged in creating shopping carts. With the help of a user-friendly smart algorithm, touch screen, and other technologies, the company streamlines the retail shopping experience by scanning purchased products and enabling in-cart payment so that customers can simply pick & go, and bypass long cashier checkout lines.